Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Autofusion in the immature spine treated with growing rods.

Cahill PJ, Marvil S, Cuddihy L, Schutt C, Idema J, Clements DH, Antonacci MD, Asghar J, Samdani AF, Betz RR.

Spine (Phila Pa 1976). 2010 Oct 15;35(22):E1199-203. doi: 10.1097/BRS.0b013e3181e21b50. Review.

PMID:
20683383
2.

Brachytherapy versus cystectomy in solitary bladder cancer: a case control, multicentre, East-Netherlands study.

van der Steen-Banasik E, Ploeg M, Witjes JA, van Rey FS, Idema JG, Heijbroek RP, Karthaus HF, Reinders JG, Viddeleer A, Visser AG.

Radiother Oncol. 2009 Nov;93(2):352-7. doi: 10.1016/j.radonc.2009.04.020. Epub 2009 May 18.

PMID:
19457565
3.

Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer.

Hendricksen K, Witjes WP, Idema JG, Kums JJ, van Vierssen Trip OB, de Bruin MJ, Vergunst H, Caris CT, Janzing-Pastors MH, Witjes JA.

Eur Urol. 2008 May;53(5):984-91. doi: 10.1016/j.eururo.2007.12.033. Epub 2007 Dec 27.

PMID:
18248876
4.

Virosomes in vaccine development: induction of cytotoxic T lymphocyte activity with virosome-encapsulated protein antigens.

Bungener L, Idema J, ter Veer W, Huckriede A, Daemen T, Wilschut J.

J Liposome Res. 2002 Feb-May;12(1-2):155-63.

PMID:
12604050
5.

Saving bladders with brachytherapy: implantation technique and results.

Van der Steen-Banasik EM, Visser AG, Reinders JG, Heijbroek RP, Idema JG, Janssen TG, Leer JW.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):622-9.

PMID:
12062605
6.

Rapid identification of bacteria in blood cultures by using fluorescently labeled oligonucleotide probes.

Jansen GJ, Mooibroek M, Idema J, Harmsen HJ, Welling GW, Degener JE.

J Clin Microbiol. 2000 Feb;38(2):814-7.

7.

A new long acting formulation of the luteinizing hormone-releasing hormone analogue goserelin: results of studies in prostate cancer.

Debruyne FM, Dijkman GA, Lee DC, Witjes WP, del Moral F, Karthaus HF, van der Mejden AP, Plasman JW, Pull HC, Kums JJ, Idema JG, Hoefakker JW, Heijbroek RP, Kil PJ, Khoe GS.

J Urol. 1996 Apr;155(4):1352-4.

PMID:
8632572
9.

A phase III randomized trial comparing the efficacy and safety of the 3-monthly 10.8-mg depot of Zoladex with the monthly 3.6-mg depot in patients with advanced prostate cancer. Dutch South East Cooperative Urological Group.

Dijkman GA, Debruyne FM, Fernandez del Moral P, Plasman JW, Hoefakker JW, Idema JG, Sykes M.

Eur Urol. 1994;26 Suppl 1:1-2. No abstract available.

PMID:
7737253

Supplemental Content

Support Center